Foghorn Therapeutics Inc. FHTX
Nov 12, 2026, 10:00 AM EST
- YTD
- -62.59%
- 1 year
- -55.41%
FHTX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-86,149,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -86,149,000 | 15,163,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -101,312,000 | 18,018,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -119,330,000 | -311,732,000 | -162.02% |
| FY 2022 | 2022-12-31 | 192,402,000 | 245,965,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -53,563,000 | -6,344,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -47,219,000 | 80,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -47,299,000 | -23,110,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -24,189,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.